Patton Albertson Miller Group, LLC Novo Nordisk A S Transaction History

Patton Albertson Miller Group, LLC

$720 Million
Q3 2024

A detailed history of Patton Albertson Miller Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Patton Albertson Miller Group, LLC holds 5,720 shares of NVO stock, worth $570,913. This represents 0.09% of its overall portfolio holdings.

Number of Shares

5,720

Previous 5,900 3.05%

Holding current value

$570,913

Previous $842,000 19.12%

% of portfolio

0.09%

Previous 0.12%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$119.07 - $145.42 $21,432 - $26,175	-180 Reduced 3.05%	5,720 $681,000
Q2 2024 Aug 02, 2024	SELL	$122.71 - $146.91 $9,816 - $11,752	-80 Reduced 1.34%	5,900 $842,000
Q1 2024 Apr 24, 2024	SELL	$102.11 - $135.92 $20,422 - $27,183	-200 Reduced 3.24%	5,980 $767,000
Q4 2023 Feb 07, 2024	SELL	$87.78 - $105.45 $17,556 - $21,090	-200 Reduced 3.13%	6,180 $639,000
Q3 2023 Oct 24, 2023	BUY	$90.94 - $199.54 $276,457 - $606,601	3,040 Added 91.02%	6,380 $580,000
Q2 2023 Jul 13, 2023	SELL	$155.98 - $172.65 $74,246 - $82,181	-476 Reduced 12.47%	3,340 $540,000
Q1 2023 Apr 21, 2023	SELL	$132.34 - $159.14 $136,839 - $164,550	-1,034 Reduced 21.32%	3,816 $607,000
Q4 2022 Jan 23, 2023	SELL	$102.55 - $135.33 $28,201 - $37,215	-275 Reduced 5.37%	4,850 $0
Q2 2022 Jul 22, 2022	SELL	$103.24 - $121.81 $51,620 - $60,905	-500 Reduced 8.89%	5,125 $571,000
Q1 2022 May 02, 2022	SELL	$93.1 - $112.54 $41,895 - $50,643	-450 Reduced 7.41%	5,625 $625,000
Q4 2021 Feb 11, 2022	SELL	$95.88 - $117.08 $15,340 - $18,732	-160 Reduced 2.57%	6,075 $680,000
Q3 2021 Oct 27, 2021	SELL	$84.42 - $106.62 $98,349 - $124,212	-1,165 Reduced 15.74%	6,235 $599,000
Q2 2021 Jul 29, 2021	SELL	$67.66 - $84.76 $25,372 - $31,785	-375 Reduced 4.82%	7,400 $620,000
Q1 2021 Apr 21, 2021	SELL	$67.06 - $75.82 $27,964 - $31,616	-417 Reduced 5.09%	7,775 $524,000
Q4 2020 Feb 25, 2021	SELL	$63.89 - $73.8 $5,302 - $6,125	-83 Reduced 1.0%	8,192 $615,000
Q1 2020 May 22, 2020	SELL	$49.46 - $64.78 $38,331 - $50,204	-775 Reduced 8.56%	8,275 $498,000
Q3 2019 Nov 13, 2019	SELL	$47.54 - $53.43 $1,949 - $2,190	-41 Reduced 0.45%	9,050 $468,000
Q2 2019 Aug 12, 2019	BUY	$46.79 - $52.47 $425,367 - $477,004	9,091 New	9,091 $457,000

Others Institutions Holding NVO

# of Institutions

1,952

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $225B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patton Albertson Miller Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patton Albertson Miller Group, LLC with notifications on news.

Account

Patton Albertson Miller Group, LLC Novo Nordisk A S Transaction History